Chonnam Med J.  2015 Apr;51(1):8-18. 10.4068/cmj.2015.51.1.8.

Comorbidity of Depression with Physical Disorders: Research and Clinical Implications

• Kang HJ
• Kim SY
• Bae KY
• Kim SW
• Shin IS
• Yoon JS
• Kim JM

• KMID: 2172142
• DOI: http://doi.org/10.4068/cmj.2015.51.1.8

Abstract

Depression is prevalent in patients with physical disorders, particularly in those with severe disorders such as cancer, stroke, and acute coronary syndrome. Depression has an adverse impact on the courses of these diseases that includes poor quality of life, more functional impairments, and a higher mortality rate. Patients with physical disorders are at higher risk of depression. This is particularly true for patients with genetic and epigenetic predictors, environmental vulnerabilities such as past depression, higher disability, and stressful life events. Such patients should be monitored closely. To appropriately manage depression in these patients, comprehensive and integrative care that includes antidepressant treatment (with considerations for adverse effects and drug interactions), treatment of the physical disorder, and collaborative care that consists of disease education, cognitive reframing, and modification of coping style should be provided. The objective of the present review was to present and summarize the prevalence, risk factors, clinical correlates, current pathophysiological aspects including genetics, and treatments for depression comorbid with physical disorders. In particular, we tried to focus on severe physical disorders with high mortality rates, such as cancer, stroke, and acute coronary syndrome, which are highly comorbid with depression. This review will enhance our current understanding of the association between depression and serious medical conditions, which will allow clinicians to develop more advanced and personalized treatment options for these patients in routine clinical practice.

Keyword

Depression; Risk factors; Prognosis

MeSH Terms

Acute Coronary Syndrome
Comorbidity*
Depression*
Education
Epigenomics
Genetics
Humans
Mortality
Prevalence
Prognosis
Quality of Life
Risk Factors
Stroke

Figure

• 

  FIG. 1 Prevalence of depression among the general population and in patients with cancer, stroke, and acute coronary syndrome.

Reference

1. Andrews G. Should depression be managed as a chronic disease? BMJ. 2001; 322:419–421. PMID: 11179166.

2. World Health Organization. The global burden of disease: 2004 update. Geneva, Switzerland: WHO Press;2008.

3. Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry. 2007; 29:147–155. PMID: 17336664.

4. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007; 370:851–858. PMID: 17826170.

5. Naylor C, Parsonage M, McDaid D, Knapp M, Fossey M, Galea A. Long-term conditions and mental health. The cost of comorbidities. London: King's Fund and Centre for Mental Health;2012.

6. IOM (Institute of Medicine). Living well with chronic illness: a call for public health action. Washington, DC: The National Academies Press;2012.

7. Egede LE. Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. Gen Hosp Psychiatry. 2007; 29:409–416. PMID: 17888807.

8. Ng CG, Boks MP, Zainal NZ, de Wit NJ. The prevalence and pharmacotherapy of depression in cancer patients. J Affect Disord. 2011; 131:1–7. PMID: 20732716.

9. Hackett ML, Pickles K. Part I: frequency of depression after stroke: an updated systematic review and meta-analysis of observational studies. Int J Stroke. 2014; 9:1017–1025. PMID: 25117911.

10. Thombs BD, Bass EB, Ford DE, Stewart KJ, Tsilidis KK, Patel U, et al. Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med. 2006; 21:30–38. PMID: 16423120.

11. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62:617–627. PMID: 15939839.

12. Kang JI, Sung NY, Park SJ, Lee CG, Lee BO. The epidemiology of psychiatric disorders among women with breast cancer in South Korea: analysis of national registry data. Psychooncology. 2014; 23:35–39. PMID: 24038620.

13. So ES. Cardiovascular disease risk factors associated with depression among Korean adults with coronary artery disease and cerebrovascular disease. Asia Pac Psychiatry. 2014; [Epub ahead of print].

14. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998; 59(Suppl 20):22–33. PMID: 9881538.

15. Kim JM, Kim SW, Stewart R, Kim SY, Shin IS, Park MH, et al. Serotonergic and BDNF genes associated with depression 1 week and 1 year after mastectomy for breast cancer. Psychosom Med. 2012; 74:8–15. PMID: 22210241.

16. Kim JM, Stewart R, Bae KY, Kim SW, Kang HJ, Shin IS, et al. Serotonergic and BDNF genes and risk of depression after stroke. J Affect Disord. 2012; 136:833–840. PMID: 22014446.

17. Kim JM, Stewart R, Kang HJ, Bae KY, Kim SW, Shin IS, et al. Serotonergic genes and depressive disorder in acute coronary syndrome: The Korean depression in ACS (K-DEPACS) study. Eur Neuropsychopharmacol. 2015; pii: S0924-977X(15)00039-5. [Epub ahead of print].

18. Cho MJ, Kim JK, Jeon HJ, Suh T, Chung IW, Hong JP, et al. Lifetime and 12-month prevalence of DSM-IV psychiatric disorders among Korean adults. J Nerv Ment Dis. 2007; 195:203–210. PMID: 17468679.

19. Annunziata MA, Muzzatti B, Giovannini L, Romito F, Cormio C, Mattioli V, et al. Is long-term cancer survivors quality of life comparable to that of the general population? An italian study. Support Care Cancer. 2015; [Epub ahead of print].

20. Carod-Artal FJ, Egido JA. Quality of life after stroke: the importance of a good recovery. Cerebrovasc Dis. 2009; 27(Suppl 1):204–214. PMID: 19342853.

21. Dickens C, Cherrington A, McGowan L. Depression and health-related quality of life in people with coronary heart disease: a systematic review. Eur J Cardiovasc Nurs. 2012; 11:265–275. PMID: 22457381.

22. Kim SY, Kim JM, Kim SW, Shin IS, Bae KY, Shim HJ, et al. Does awareness of terminal status influence survival and quality of life in terminally ill cancer patients? Psychooncology. 2013; [Epub ahead of print].

23. Jeong BO, Kang HJ, Bae KY, Kim SW, Kim JM, Shin IS, et al. Determinants of quality of life in the acute stage following stroke. Psychiatry Investig. 2012; 9:127–133.

24. Kim SY, Kim JM, Stewart R, Kang HJ, Kim SW, Shin IS, et al. Influences of personality traits on quality of life after stroke. Eur Neurol. 2013; 69:185–192. PMID: 23306809.

25. Yoon S, Jenog BO, Kang HJ, Kim SY, Bae KY, Kim SW, et al. Predictors of quality of life in subacute stage of stroke. J Korean Soc Depress Bipolar Disord. 2013; 11:1–6.

26. Kim JM, Stewart R, Bae KY, Kang HJ, Kim SW, Shin IS, et al. Effects of depression co-morbidity and treatment on quality of life in patients with acute coronary syndrome: the Korean depression in ACS (K-DEPACS) and the escitalopram for depression in ACS (EsDEPACS) study. Psychol Med. 2014; 1–12.

27. Sullivan M, Levy WC, Russo JE, Spertus JA. Depression and health status in patients with advanced heart failure: a prospective study in tertiary care. J Card Fail. 2004; 10:390–396. PMID: 15470649.

28. Von Korff M, Katon WJ, Lin EH, Ciechanowski P, Peterson D, Ludman EJ, et al. Functional outcomes of multi-condition collaborative care and successful ageing: results of randomised trial. BMJ. 2011; 343:d6612. PMID: 22074851.

29. Kutlubaev MA, Hackett ML. Part II: predictors of depression after stroke and impact of depression on stroke outcome: an updated systematic review of observational studies. Int J Stroke. 2014; 9:1026–1036. PMID: 25156411.

30. Kim JM, Stewart R, Park MS, Kang HJ, Kim SW, Shin IS, et al. Associations of BDNF genotype and promoter methylation with acute and long-term stroke outcomes in an East Asian cohort. PLoS One. 2012; 7:e51280. PMID: 23240009.

31. Kang HJ, Stewart R, Park MS, Bae KY, Kim SW, Kim JM, et al. White matter hyperintensities and functional outcomes at 2 weeks and 1 year after stroke. Cerebrovasc Dis. 2013; 35:138–145. PMID: 23406918.

32. Pinquart M, Duberstein PR. Depression and cancer mortality: a meta-analysis. Psychol Med. 2010; 40:1797–1810. PMID: 20085667.

33. Ayerbe L, Ayis S, Wolfe CD, Rudd AG. Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis. Br J Psychiatry. 2013; 202:14–21. PMID: 23284148.

34. Ayerbe L, Ayis S, Crichton S, Wolfe CD, Rudd AG. The long-term outcomes of depression up to 10 years after stroke; the South London Stroke Register. J Neurol Neurosurg Psychiatry. 2014; 85:514–521. PMID: 24163430.

35. Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014; 129:1350–1369. PMID: 24566200.

36. Bhattarai N, Charlton J, Rudisill C, Gulliford MC. Prevalence of depression and utilization of health care in single and multiple morbidity: a population-based cohort study. Psychol Med. 2013; 43:1423–1431. PMID: 23114010.

37. Rutledge T, Vaccarino V, Johnson BD, Bittner V, Olson MB, Linke SE, et al. Depression and cardiovascular health care costs among women with suspected myocardial ischemia: prospective results from the WISE (Women's Ischemia Syndrome Evaluation) Study. J Am Coll Cardiol. 2009; 53:176–183. PMID: 19130986.

38. Simon GE, VonKorff M, Barlow W. Health care costs of primary care patients with recognized depression. Arch Gen Psychiatry. 1995; 52:850–856. PMID: 7575105.

39. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron. 2002; 34:13–25. PMID: 11931738.

40. Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Kim YH, et al. Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders. Biol Psychiatry. 2007; 62:423–428. PMID: 17482146.

41. Heils A, Teufel A, Petri S, Seemann M, Bengel D, Balling U, et al. Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene. J Neural Transm Gen Sect. 1995; 102:247–254. PMID: 8788073.

42. Anguelova M, Benkelfat C, Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders. Mol Psychiatry. 2003; 8:574–591. PMID: 12851635.

43. Polesskaya OO, Sokolov BP. Differential expression of the "C" and "T" alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics. J Neurosci Res. 2002; 67:812–822. PMID: 11891796.

44. Parsons MJ, D'Souza UM, Arranz MJ, Kerwin RW, Makoff AJ. The -1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity. Biol Psychiatry. 2004; 56:406–410. PMID: 15364038.

45. Enoch MA, Goldman D, Barnett R, Sher L, Mazzanti CM, Rosenthal NE. Association between seasonal affective disorder and the 5-HT2A promoter polymorphism, -1438G/A. Mol Psychiatry. 1999; 4:89–92. PMID: 10089016.

46. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001; 24:677–736. PMID: 11520916.

47. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003; 112:257–269. PMID: 12553913.

48. Hosang GM, Shiles C, Tansey KE, McGuffin P, Uher R. Interaction between stress and the BDNF Val66Met polymorphism in depression: a systematic review and meta-analysis. BMC Med. 2014; 12:7. PMID: 24433458.

49. Misener VL, Gomez L, Wigg KG, Luca P, King N, Kiss E, et al. International Consortium for Childhood-Onset Mood Disorders. Cytokine Genes TNF, IL1A, IL1B, IL6, IL1RN and IL10, and childhood-onset mood disorders. Neuropsychobiology. 2008; 58:71–80. PMID: 18832862.

50. Bogdan R, Hyde LW, Hariri AR. A neurogenetics approach to understanding individual differences in brain, behavior, and risk for psychopathology. Mol Psychiatry. 2013; 18:288–299. PMID: 22614291.

51. Uher R. Genes, environment, and individual differences in responding to treatment for depression. Harv Rev Psychiatry. 2011; 19:109–124. PMID: 21631158.

52. Roth TL, Lubin FD, Funk AJ, Sweatt JD. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol Psychiatry. 2009; 65:760–769. PMID: 19150054.

53. Fuchikami M, Morinobu S, Segawa M, Okamoto Y, Yamawaki S, Ozaki N, et al. DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. PLoS One. 2011; 6:e23881. PMID: 21912609.

54. Devlin AM, Brain U, Austin J, Oberlander TF. Prenatal exposure to maternal depressed mood and the MTHFR C677T variant affect SLC6A4 methylation in infants at birth. PLoS One. 2010; 5:e12201. PMID: 20808944.

55. Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Yoon JS. Modification by two genes of associations between general somatic health and incident depressive syndrome in older people. Psychosom Med. 2009; 71:286–291. PMID: 19251870.

56. Kim JM, Stewart R, Kim SW, Kim SY, Bae KY, Kang HJ, et al. Physical health and incident late-life depression: modification by cytokine genes. Neurobiol Aging. 2013; 34:356.e1–356.e9. PMID: 22921153.

57. Gilbert J, Haman KL, Dietrich MS, Blakely RD, Shelton RC, Murphy BA. Depression in patients with head and neck cancer and a functional genetic polymorphism of the serotonin transporter gene. Head Neck. 2012; 34:359–364. PMID: 21604315.

58. Grassi L, Rossi E, Cobianchi M, Aguiari L, Capozzo M, Martinis E, et al. Depression and serotonin transporter (5-HTTLPR) polymorphism in breast cancer patients. J Affect Disord. 2010; 124:346–350. PMID: 20122741.

59. Kim JM, Kang HJ, Jang JE, Kim SY, Kim SW, Shin IS, et al. Interleukin-1β-511C/T gene polymorphism and depression related to breast cancer. J Korean Soc Depress Bipolar Disord. 2011; 9:189–193.

60. Kim JM, Stewart R, Kim SY, Kang HJ, Jang JE, Kim SW, et al. A one year longitudinal study of cytokine genes and depression in breast cancer. J Affect Disord. 2013; 148:57–65. PMID: 23276701.

61. Kang HJ, Kim JM, Kim SY, Kim SW, Shin IS, Kim HR, et al. A longitudinal study of BDNF promoter methylation and depression in breast cancer. Psychiatry Investig. [In Press].

62. Mak KK, Kong WY, Mak A, Sharma VK, Ho RC. Polymorphisms of the serotonin transporter gene and post-stroke depression: a meta-analysis. J Neurol Neurosurg Psychiatry. 2013; 84:322–328. PMID: 23236014.

63. Tang WK, Tang N, Liao CD, Liang HJ, Mok VC, Ungvari GS, et al. Serotonin receptor 2C gene polymorphism associated with post-stroke depression in Chinese patients. Genet Mol Res. 2013; 12:1546–1553. PMID: 23765961.

64. Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Kim YH, et al. BDNF genotype potentially modifying the association between incident stroke and depression. Neurobiol Aging. 2008; 29:789–792. PMID: 17222482.

65. Kim JM, Stewart R, Kim SW, Shin IS, Kim JT, Park MS, et al. Associations of cytokine gene polymorphisms with post-stroke depression. World J Biol Psychiatry. 2012; 13:579–587. PMID: 21793642.

66. Kim JM, Stewart R, Kang HJ, Kim SW, Shin IS, Kim HR, et al. A longitudinal study of SLC6A4 DNA promoter methylation and poststroke depression. J Psychiatr Res. 2013; 47:1222–1227. PMID: 23702251.

67. Kim JM, Stewart R, Kang HJ, Kim SY, Kim SW, Shin IS, et al. A longitudinal study of BDNF promoter methylation and genotype with poststroke depression. J Affect Disord. 2013; 149:93–99. PMID: 23399480.

68. McCaffery JM, Frasure-Smith N, Dubé MP, Théroux P, Rouleau GA, Duan Q, et al. Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psychosom Med. 2006; 68:187–200. PMID: 16554382.

69. Nakatani D, Sato H, Sakata Y, Shiotani I, Kinjo K, Mizuno H, et al. Osaka Acute Coronary Insufficiency Study Group. Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am Heart J. 2005; 150:652–658. PMID: 16209960.

70. Otte C, McCaffery J, Ali S, Whooley MA. Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the Heart and Soul Study. Am J Psychiatry. 2007; 164:1379–1384. PMID: 17728423.

71. Bozzini S, Gambelli P, Boiocchi C, Schirinzi S, Falcone R, Buzzi P, et al. Coronary artery disease and depression: possible role of brain-derived neurotrophic factor and serotonin transporter gene polymorphisms. Int J Mol Med. 2009; 24:813–818. PMID: 19885623.

72. Liu YQ, Su GB, Duan CH, Wang JH, Liu HM, Feng N, et al. Brain-derived neurotrophic factor gene polymorphisms are associated with coronary artery disease-related depression and antidepressant response. Mol Med Rep. 2014; 10:3247–3253. PMID: 25324022.

73. Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ. 2005; 330:702. PMID: 15695497.

74. Bardwell WA, Natarajan L, Dimsdale JE, Rock CL, Mortimer JE, Hollenbach K, et al. Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer. J Clin Oncol. 2006; 24:2420–2427. PMID: 16651649.

75. Kim SY, Stewart R, Kim SW, Yang SJ, Kim JM, Shin IS, et al. Predictors of depression in Korean breast cancer patients: A one year longitudinal study. Asia-Pacific Psychiatry. 2012; 4:250–257.

76. Kim SW, Kim SY, Kim JM, Park MH, Yoon JH, Shin MG, et al. Relationship between a hopeful attitude and cellular immunity in patients with breast cancer. Gen Hosp Psychiatry. 2011; 33:371–376. PMID: 21762834.

77. Kang HJ, Bae KY, Kim SW, Kim JM, Shin IS, Kim JT, et al. Prevalence and risk factors of post-stroke depression. J Korean Soc Depress Bipolar Disord. 2011; 9:57–63.

78. Doyle F, McGee HM, Conroy RM, Delaney M. What predicts depression in cardiac patients: sociodemographic factors, disease severity or theoretical vulnerabilities? Psychol Health. 2011; 26:619–634. PMID: 21038172.

79. Naqvi TZ, Rafique AM, Andreas V, Rahban M, Mirocha J, Naqvi SS. Predictors of depressive symptoms post-acute coronary syndrome. Gend Med. 2007; 4:339–351. PMID: 18215725.

80. Rayner L, Price A, Evans A, Valsraj K, Higginson IJ, Hotopf M. Antidepressants for depression in physically ill people. Cochrane Database Syst Rev. 2010; (3):CD007503. PMID: 20238354.

81. Kim JM, Stewart R, Bae KY, Yang SJ, Yoon JS, Jung SW, et al. Physical comorbidity and 12-week treatment outcomes in Korean patients with depressive disorders: the CRESCEND study. J Psychosom Res. 2011; 71:311–318. PMID: 21999974.

82. Laoutidis ZG, Mathiak K. Antidepressants in the treatment of depression/depressive symptoms in cancer patients: a systematic review and meta-analysis. BMC Psychiatry. 2013; 13:140. PMID: 23679841.

83. Rayner L, Price A, Evans A, Valsraj K, Hotopf M, Higginson IJ. Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis. Palliat Med. 2011; 25:36–51. PMID: 20935027.

84. Riblet N, Larson R, Watts BV, Holtzheimer P. Reevaluating the role of antidepressants in cancer-related depression: a systematic review and meta-analysis. Gen Hosp Psychiatry. 2014; 36:466–473. PMID: 24950919.

85. Hart SL, Hoyt MA, Diefenbach M, Anderson DR, Kilbourn KM, Craft LL, et al. Meta-analysis of efficacy of interventions for elevated depressive symptoms in adults diagnosed with cancer. J Natl Cancer Inst. 2012; 104:990–1004. PMID: 22767203.

86. Kim SW, Lee SY, Kim JM. Depression in cancer patients. Korean J Biol Psychiatry. 2006; 13:59–69.

87. Kim SY, Kim JM, Kim SW, Shin IS, Yoon JS, Shim HJ. Management of depression in terminally ill cancer patients. Korean J Psychopharmacol. 2010; 21:51–61.

88. Hackett ML, Anderson CS, House A, Xia J. Interventions for treating depression after stroke. Cochrane Database Syst Rev. 2008; (4):CD003437. PMID: 18843644.

89. Kim JM, Stewart R, Kang HJ, Bae KY, Kim SW, Shin IS, et al. A prospective study of statin use and poststroke depression. J Clin Psychopharmacol. 2014; 34:72–79. PMID: 24304857.

90. Kim JM, Shin HY. Diagnosis and treatment of poststroke depression. Korean J Biol Psychiatry. 2005; 12:89–97.

91. Kang HJ, Kim SW, Kim JM, Shin IS, Yoon JS. Pathogenesis of post-stroke depression : a bio-psycho-social integrative model. J Korean Neuropsychiatr Assoc. 2011; 50:347–353.

92. Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with coronary artery disease. Cochrane Database Syst Rev. 2011; (9):CD008012. PMID: 21901717.

93. Kim JM, Bae KY, Stewart R, Jung BO, Kang HJ, Kim SW, et al. Escitalopram treatment for depressive disorder following acute coronary syndrome: a 24-week double-blind, placebo-controlled trial. J Clin Psychiatry. 2015; 76:62–68. PMID: 25375836.

94. Kim JM, Bae KY, Kang HJ, Kim SW, Shin IS, Hong YJ, et al. Design and methodology for the Korean observational and escitalopram treatment studies of depression in acute coronary syndrome: K-DEPACS and EsDEPACS. Psychiatry Investig. 2014; 11:89–94.

95. Gunn J, Diggens J, Hegarty K, Blashki G. A systematic review of complex system interventions designed to increase recovery from depression in primary care. BMC Health Serv Res. 2006; 6:88. PMID: 16842629.

96. Archer J, Bower P, Gilbody S, Lovell K, Richards D, Gask L, et al. Collaborative care for depression and anxiety problems. Cochrane Database Syst Rev. 2012; 10:CD006525. PMID: 23076925.

97. NICE. Depression in adults with a chronic physical health problem. The NICE Guideline on Treatment and Management. National Clinical Practice Guideline 91. British Psychological Society and Royal College of Psychiatrists;2010.

98. Coventry P, Lovell K, Dickens C, Bower P, Chew-Graham C, McElvenny D, et al. Integrated primary care for patients with mental and physical multimorbidity: cluster randomised controlled trial of collaborative care for patients with depression comorbid with diabetes or cardiovascular disease. BMJ. 2015; 350:h638. PMID: 25687344.

99. Sharpe M, Walker J, Holm Hansen C, Martin P, Symeonides S, Gourley C, et al. Symptom Management Research Trials) Oncology-2 Team. Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial. Lancet. 2014; 384:1099–1108. PMID: 25175478.

100. Ekers D, Murphy R, Archer J, Ebenezer C, Kemp D, Gilbody S. Nurse-delivered collaborative care for depression and long-term physical conditions: a systematic review and meta-analysis. J Affect Disord. 2013; 149:14–22. PMID: 23545062.